Business Standard

Friday, January 10, 2025 | 07:31 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Sun Pharma Q4 net profit at Rs 635.88 crore; sales in US jump 20%

The company had posted a net profit of Rs 1,342.50 crore for the corresponding period of the previous fiscal

Sun Pharma
Premium

Press Trust of India New Delhi
Drug major Sun Pharmaceutical Industries Tuesday reported a consolidated net profit of Rs 635.88 crore for the fourth quarter ended on March 31, 2019.

The company had posted a net profit of Rs 1,342.50 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries said in a filing to BSE.

The profit was mainly impacted by distribution change for its India business.

The company said the net profit for the fourth quarter of FY2018-19 is not comparable with the year-ago period due to the one-time impact of distribution change for India business in the fourth quarter of 2018-19
Topics : Sun Pharma

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in